Guangzhou Baiy traded at 30.52 this Thursday July 7th, decreasing 0.10 or 0.33 percent since the previous trading session. Looking back, over the last four weeks, Guangzhou Baiy lost 2.09 percent. Over the last 12 months, its price fell by 6.84 percent. Looking ahead, we forecast Guangzhou Baiy to be priced at 30.08 by the end of this quarter and at 27.56 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
30.52
Daily Change
-0.33%
Yearly
-6.84%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Sh Fosun Pharma 47.23 -1.05 -2.17% -24.79%
Jiangsu Hengrui Me. 38.82 -0.60 -1.52% -36.74%
Sh Pharmaceutical 17.89 -0.08 -0.45% -10.51%
Aspen Pharmacare 13,581.00 381.00 2.89% -18.01%
Cipla 945.60 8.20 0.87% -2.03%
Dr.Reddys Laboratories 4,390.00 -4.20 -0.10% -21.07%
Kalbe Farma 1,675.00 -10.00 -0.59% 23.62%
Richter Gedeon 7,225.00 190.00 2.70% -11.13%
Sun Pharmaceuticals 837.70 1.90 0.23% 23.17%
Teva Pharmaceutical Industries Ltd 2,656.00 -90.00 -3.28% -14.29%

Indexes Price Day Year
SHANGHAI 3372 11.51 0.34% -4.34%

Guangzhou Baiy
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd i is engaged in the pharmaceutical and healthcare industry. The Company's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The Company's Great South TCM includes research, development, manufacturing and sales for Chinese and western medicine, chemical raw medicine, natural drug, biological medicine and intermediates of chemical raw medicine. The Company's Great Health segment includes the research, development, manufacturing and sales of beverages, foods, health products and other products. The Company's Great Commerce segment includes wholesale, retail, import and export for western medicine, Chinese medicine and medical apparatus and instruments. The Great Medical segment is engaged in medical services, traditional Chinese medicine health preservation, modern pension and medical equipment industry.